NATERA INC's ticker is NTRA and the CUSIP is 632307104. A total of 289 filers reported holding NATERA INC in Q1 2022. The put-call ratio across all filers is 0.36 and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $72,744,749 | -9.7% | 1,643,669 | -0.7% | 0.01% | 0.0% |
Q2 2023 | $80,543,572 | -5.5% | 1,655,231 | +7.8% | 0.01% | -18.2% |
Q1 2023 | $85,212,579 | +143292.8% | 1,534,808 | +3.7% | 0.01% | +37.5% |
Q4 2022 | $59,426 | -99.9% | 1,479,376 | +17.2% | 0.01% | 0.0% |
Q3 2022 | $55,314,000 | +33.5% | 1,262,309 | +8.0% | 0.01% | +33.3% |
Q2 2022 | $41,429,000 | -11.8% | 1,168,999 | +1.2% | 0.01% | 0.0% |
Q1 2022 | $46,996,000 | -55.4% | 1,155,285 | +2.5% | 0.01% | -53.8% |
Q4 2021 | $105,258,000 | -13.4% | 1,127,087 | +3.3% | 0.01% | -18.8% |
Q3 2021 | $121,563,000 | +4.5% | 1,090,844 | +6.5% | 0.02% | 0.0% |
Q2 2021 | $116,280,000 | -13.6% | 1,024,225 | -22.7% | 0.02% | -23.8% |
Q1 2021 | $134,542,000 | +9.7% | 1,325,018 | +7.5% | 0.02% | 0.0% |
Q4 2020 | $122,647,000 | +54.5% | 1,232,393 | +12.2% | 0.02% | +31.2% |
Q3 2020 | $79,360,000 | +52.2% | 1,098,572 | +5.0% | 0.02% | +45.5% |
Q2 2020 | $52,153,000 | +77.4% | 1,046,006 | +6.2% | 0.01% | +37.5% |
Q1 2020 | $29,405,000 | -52.4% | 984,784 | -46.3% | 0.01% | +33.3% |
Q4 2019 | $61,758,000 | +127.7% | 1,833,180 | +121.6% | 0.01% | 0.0% |
Q3 2019 | $27,128,000 | +20.8% | 827,097 | +1.6% | 0.01% | +20.0% |
Q2 2019 | $22,452,000 | +113.6% | 814,126 | +59.7% | 0.01% | +66.7% |
Q1 2019 | $10,510,000 | -18.7% | 509,725 | -45.0% | 0.00% | +50.0% |
Q4 2018 | $12,926,000 | +23.8% | 926,058 | +112.3% | 0.00% | -33.3% |
Q3 2018 | $10,443,000 | +47.2% | 436,258 | +15.7% | 0.00% | +50.0% |
Q2 2018 | $7,094,000 | +114.9% | 376,995 | +5.9% | 0.00% | +100.0% |
Q1 2018 | $3,301,000 | +4.1% | 356,123 | +0.9% | 0.00% | 0.0% |
Q4 2017 | $3,172,000 | -27.4% | 352,850 | +4.0% | 0.00% | -50.0% |
Q3 2017 | $4,371,000 | +55.9% | 339,142 | +31.4% | 0.00% | +100.0% |
Q2 2017 | $2,803,000 | +34.4% | 258,110 | +9.7% | 0.00% | 0.0% |
Q1 2017 | $2,086,000 | -20.6% | 235,287 | +4.8% | 0.00% | 0.0% |
Q4 2016 | $2,628,000 | +8.6% | 224,474 | +3.0% | 0.00% | 0.0% |
Q3 2016 | $2,420,000 | +67.6% | 217,905 | +82.0% | 0.00% | 0.0% |
Q2 2016 | $1,444,000 | +70.9% | 119,756 | +34.9% | 0.00% | – |
Q1 2016 | $845,000 | +11.3% | 88,776 | +26.3% | 0.00% | – |
Q4 2015 | $759,000 | +35.3% | 70,287 | +35.7% | 0.00% | – |
Q3 2015 | $561,000 | – | 51,778 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Blue Water Life Science Advisors, LP | 797,436 | $35,286,543 | 33.31% |
Kynam Capital Management, LP | 3,003,668 | $132,912,309 | 21.74% |
Eversept Partners, LP | 2,492,636 | $110,299,143 | 9.33% |
Sofinnova Investments, Inc. | 3,100,560 | $137,199,780 | 8.66% |
Eagle Health Investments LP | 595,694 | $26,359,460 | 5.81% |
BEACONLIGHT CAPITAL, LLC | 259,865 | $11,499,026 | 4.97% |
Lagoda Investment Management, L.P. | 165,465 | $7,321,826 | 4.81% |
Tri Locum Partners LP | 274,795 | $12,159,679 | 3.89% |
Bain Capital Life Sciences Investors, LLC | 700,197 | $30,983,717 | 3.46% |
SAMLYN CAPITAL, LLC | 4,400,226 | $194,710,000 | 3.18% |